HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

plaferon

a natural protein-peptide preparation; an antihypoxic agent; - "formerly known as plaferon"; no furthur information available 3/95; 5/97

Also Known As:

preparation LB

Networked: 22 relevant articles (2 outcomes, 6 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Nerve Tissue Proteins: 2
    - Neuropeptides: 6772
      - plaferon: 22
- Peptides: 82426
  - Neuropeptides: 6772
    - plaferon: 22

Experts

1.	Nakashidze, I M: 2 articles (06/2009 - 06/2009)
2.	Belikov, Iu N: 2 articles (05/2007 - 05/2007)
3.	Iashvili, B P: 2 articles (05/2007 - 05/2007)
4.	Matsaberidze, G Sh: 2 articles (05/2007 - 05/2007)
5.	Vadachkoriia, E O: 2 articles (05/2007 - 05/2007)
6.	Datunashvili, I V: 2 articles (05/2006 - 11/2005)
7.	Kasrashvili, M V: 2 articles (05/2006 - 02/2005)
8.	Kupradze, S A: 2 articles (07/2005 - 01/2005)
9.	Bakhtadze, Sophia: 1 article (02/2013)
10.	Beridze, Maia: 1 article (02/2013)

Related Diseases

1.	Infarction (Infarctions) 02/01/2013 - "The treatment with Plaferon-LB 0.5 hr before illumination resulted in a significant reduction of the median infarct size in the insult-alone group. " 01/01/1996 - "[The role of preparation LB in forming a thrombotic infarct of the cerebral cortex]." 02/01/2013 - "The infarct volume, cerebral tissue oxygen tension, cerebral blood flow, and capillary damage were measured in the following groups: untreated control rats, Plaferon-LB-alone rats, insult-alone rats, and insult in Plaferon-LB pretreated rats. "
2.	Asthma (Bronchial Asthma) 12/01/2006 - "[Effect of plaferon in children treated for bronchial asthma]." 10/01/2005 - "It may be concluded long-term plaferon treatment provides an effective and safe alternative to traditional bronchodilator drugs in the management of childhood asthma." 12/01/2006 - "54 children with well-documented asthma (27 atopic and 27 nonatopic patients) were examined for peripherial blood serum immunoglobulins content in order to determine specific immunologic triggers of formation bronchial hyperreactivity, as well for their changes using inhaled method of treatment with Plaferon LB. "
3.	Traumatic Shock 04/01/2006 - "In the present study, we attempted to evaluate the influence of plaferon LB on the liver injury in two experimental models: immune-mediated and mechanical (traumatic shock) liver damage models. " 06/01/2009 - "[The condition of oxidation-antioxidation balance of kidney and suprarenal tissue in experimental traumatic shock with white rats and the influence of Plaferon LB]." 04/01/2006 - "The results of our study demonstrated that plaferon LB decreased levels of NO in traumatic shock, but enhanced NO expression on con-A induced hepatitis. " 06/01/2009 - "[The changes of content of TNF-alpha, nitric oxide and FeS-NO in patients blood with traumatic shock under Plaferon LB influence]."
4.	Brain Infarction 01/01/1996 - "Non-invasion model for photochemically induced brain infarction was used to study the effect of a the new anti-ischemic drug LB ("Plaferon") in albino rats. "
5.	Reperfusion Injury 07/01/2007 - "The main goal of research was to study potential of Plaferon LB for cardiac preconditioning during experimental ischemia/reperfusion injury in rabbits. " 07/01/2007 - "[Use of Plaferon LB for cardiac preconditioning during experimental ischemia/reperfusion injury in rabbits]."

Related Drugs and Biologics

1.	Bronchodilator Agents (Bronchodilators)
2.	Silver Sulfadiazine (SSD)
3.	Oxygen (Dioxygen)
4.	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
5.	Nitric Oxide (Nitrogen Monoxide)
6.	Lipids
7.	Interferons
8.	Immunoglobulins (Immunoglobulin)
9.	Hormones (Hormone)
10.	Ascorbic Acid (Vitamin C)